object
case
commun
acquir
pneumonia
cap
known
blood
cultur
low
yield
rare
affect
clinic
outcom
despit
mani
studi
predict
likelihood
bacteremia
cap
patient
result
rare
implement
clinic
practic
use
blood
cultur
cap
still
increas
studi
evalu
impact
implement
previous
deriv
valid
bacteremia
predict
rule
method
registrybas
studi
use
piecewis
regress
analysi
compar
blood
cultur
rate
implement
predict
rule
also
compar
mortal
emerg
depart
ed
length
stay
timeinterv
initi
antibiot
ed
arriv
chang
antibiot
regimen
result
blood
cultur
subgroup
analysi
compar
two
group
without
use
predict
rule
implement
period
use
propens
score
match
result
follow
implement
blood
cultur
rate
declin
p
without
signific
chang
mortal
antibiot
regimen
interv
initi
antibiot
min
vs
min
p
length
stay
min
vs
min
p
significantli
chang
subgroup
analysi
group
use
predict
rule
show
min
faster
antibiot
initi
p
min
shorter
length
stay
p
group
use
rule
conclus
implement
bacteremia
predict
rule
cap
patient
reduc
blood
cultur
rate
without
affect
mortal
antibiot
regimen
blood
cultur
antibiot
treatment
routin
diagnost
test
patient
presum
infecti
howev
patient
commun
acquir
pneumonia
cap
known
rate
true
posit
blood
cultur
b
emerg
depart
ed
true
posit
result
blood
cultur
rare
affect
patient
manag
addit
ed
overcrowd
may
increas
risk
blood
cultur
contamin
part
effort
reduc
unnecessari
blood
cultur
improv
yield
blood
cultur
cap
mani
studi
describ
bacteremia
predict
rule
despit
studi
recent
studi
report
blood
cultur
rate
cap
patient
still
increas
therefor
whether
decis
rule
clinic
impact
reduct
blood
cultur
question
clinic
decis
rule
impact
standard
treatment
clinic
decis
rule
pass
three
stage
deriv
valid
implement
previou
studi
deriv
bacteremia
predict
model
cap
patient
test
generaliz
rule
multicent
extern
valid
evalu
impact
implement
bacteremia
predict
model
rate
blood
cultur
hypothes
implement
may
reduc
blood
cultur
rate
without
chang
mortal
rate
also
without
blood
cultur
time
interv
patient
present
ed
first
intraven
antibiot
administr
could
shorten
well
length
ed
stay
studi
uncontrol
studi
base
upon
retrospect
review
patient
registri
databas
implement
bacteremia
predict
rule
prospect
registri
patient
diagnos
pneumonia
ed
place
sinc
registri
includ
patient
baselin
characterist
comorbid
time
variabl
ed
arriv
time
ed
discharg
time
includ
registri
well
initi
antibiot
administr
time
registri
also
provid
patient
initi
vital
sign
laboratori
find
includ
blood
cultur
result
blood
cultur
perform
final
patient
disposit
ed
includ
admiss
ward
icu
well
mortal
includ
registri
studi
perform
tertiari
academ
hospit
annual
ed
censu
patient
approv
institut
review
board
hospit
implement
bacteremia
predict
rule
initi
januari
retrospect
analyz
patient
registri
data
januari
januari
exclus
criteria
previou
studi
short
exclud
patient
diagnos
hospitalacquir
pneumonia
hap
health
careassoci
pneumonia
hcap
ventilatorassoci
pneumonia
vap
also
exclud
patient
transfer
hospit
difficulti
followup
limit
inform
chang
antibiot
eas
use
bacteremia
predict
rule
creat
excel
file
recommend
blood
cultur
appear
riskstratifi
score
calcul
automat
entri
variabl
supplementari
fig
resid
physician
ed
chang
monthli
accord
rotat
system
hospit
instruct
excel
file
explan
predict
rule
introduc
first
wednesday
everi
month
emerg
physician
encourag
record
score
calcul
excel
file
electron
medic
record
emr
patient
suspect
pneumonia
regardless
perform
blood
cultur
predict
rule
use
record
emerg
physician
report
feedback
three
time
week
primari
outcom
blood
cultur
rate
implement
bacteremia
predict
rule
secondari
outcom
includ
mortal
rate
ed
length
stay
timeinterv
initi
antibiot
ed
arriv
chang
antibiot
regimen
result
blood
cultur
find
cost
analysi
reduc
blood
cultur
usag
due
intervent
compar
mean
cost
blood
cultur
per
patient
implement
predict
rule
posit
blood
cultur
result
thoroughli
review
result
includ
preliminari
report
final
report
time
preliminari
result
gram
stain
result
speci
grow
cultur
bottl
report
final
report
exact
name
identifi
pathogen
report
antibiot
suscept
test
result
chang
antibiot
regimen
follow
blood
cultur
result
review
daili
antibiot
administr
exact
time
h
final
result
report
time
advers
event
due
contamin
defin
unnecessari
administr
vancomycin
start
administr
preliminari
report
discontinu
follow
identif
contamin
final
report
addit
unnecessari
followup
blood
cultur
defin
blood
cultur
perform
preliminari
report
confirm
contamin
final
report
followup
result
neg
follow
isol
identifi
contamin
coagulaseneg
staphylococcu
bacillu
speci
micrococcu
speci
corynebacterium
speci
propionibacterium
speci
continu
variabl
present
mean
standard
deviat
binomi
variabl
present
frequenc
occurr
wilcoxon
ranksum
test
chisquar
test
fisher
exact
test
perform
appropri
comparison
intervent
p
valu
p
valu
b
consid
statist
signific
adopt
piecewis
regress
discontinu
approach
use
gener
linear
model
use
odd
binari
result
evalu
impact
intervent
adjust
intervent
effect
construct
multivari
linear
regress
model
use
variabl
statist
signific
p
valu
b
comparison
intervent
addit
perform
boxpierc
test
identifi
statist
signific
autocorrel
time
seri
model
use
p
valu
b
irrespect
predict
rule
blood
cultur
rate
could
reduc
educ
introduc
low
yield
blood
cultur
cap
perform
subgroup
analysi
use
patient
intervent
subgroup
analysi
use
propens
score
match
analysi
compar
group
use
predict
rule
compar
blood
cultur
rate
timeinterv
initi
antibiot
ed
length
stay
group
analys
perform
use
stata
version
statacorp
colleg
station
tx
patient
miss
variabl
includ
analys
regist
patient
studi
period
total
patient
includ
studi
patient
exclud
fig
among
elig
patient
patient
assign
intervent
group
respect
among
patient
intervent
patient
bacteremia
score
record
emr
tabl
summar
baselin
characterist
two
group
implement
bacteremia
predict
rule
blood
cultur
rate
decreas
repres
reduct
confid
interv
ci
p
tabl
addit
monthli
trend
blood
cultur
rate
chang
increas
decreas
fig
model
adjust
blood
cultur
rate
decreas
repres
reduct
ci
p
reduct
monthli
trend
blood
cultur
rate
still
appear
decreas
implement
intervent
tabl
implement
mortal
rate
decreas
ci
ci
p
b
howev
model
adjust
differ
statist
signific
p
tabl
timeinterv
initi
antibiot
ed
arriv
decreas
min
min
reach
statist
signific
p
model
adjust
statist
signific
differ
found
two
group
tabl
implement
ed
length
stay
also
decreas
min
min
differ
two
group
statist
signific
tabl
tabl
show
blood
cultur
result
intervent
overal
blood
cultur
contamin
rate
implement
blood
cultur
contamin
rate
chang
p
antibiot
regimen
chang
base
posit
blood
cultur
result
significantli
differ
two
group
implement
vs
implement
p
among
patient
contamin
undergo
unnecessari
phlebotomi
followup
blood
cultur
administ
unnecessari
vancomycin
treatment
score
implement
total
advers
event
rate
decreas
howev
differ
reach
statist
signific
p
propens
score
match
subgroup
analysi
compar
two
group
use
predict
rule
intervent
period
supplementari
tabl
baselin
characterist
two
group
similar
group
bacteremia
score
lower
blood
cultur
rate
group
use
bacteremia
score
vs
p
b
addit
group
use
predict
rule
shorter
timeinterv
initi
antibiot
min
vs
min
p
reduc
ed
length
stay
min
vs
min
p
time
seri
analysi
studi
report
implement
bacteremia
predict
rule
success
reduc
blood
cultur
rate
without
signific
mortal
antibiot
regimen
chang
blood
cultur
techniqu
timeconsum
resourceconsum
consid
need
asept
techniqu
venou
access
two
site
especi
ed
well
known
blood
cultur
contamin
common
mani
ed
higher
contamin
rate
clinic
laboratori
standard
institut
clsi
recommend
fals
posit
result
blood
cultur
associ
increas
medic
cost
hospit
length
stay
clinic
blood
cultur
contamin
result
unnecessari
antibiot
administr
one
previou
studi
addit
unnecessari
glycopeptid
administr
pseudobacteremia
case
observ
consist
result
tabl
multidrug
resist
pathogen
pneumonia
increas
concern
exist
treatment
failur
without
initi
blood
cultur
howev
recent
studi
multidrug
resist
pathogen
uncommon
cap
patient
account
accord
bacteremia
score
system
blood
cultur
could
omit
patient
lowrisk
group
true
bacteremia
rate
studi
true
bacteremia
lowrisk
group
antibiot
step
due
multidrug
resist
organ
isol
blood
cultur
concern
advers
event
rate
due
fals
posit
blood
cultur
seem
reason
omit
blood
cultur
lowrisk
group
tabl
contrari
hypothesi
time
initi
antibiot
ed
length
stay
tend
decreas
statist
signific
differ
measur
intervent
group
tabl
accord
sepsi
guidelin
initi
antibiot
administ
within
h
recognit
sepsi
patient
sever
initi
present
ed
physician
may
urg
initi
iv
antibiot
blood
cultur
without
adher
bacteremia
score
calcul
bacteremia
score
take
h
score
system
includ
albumin
creactiv
protein
result
fact
may
bacteremia
score
adher
group
mild
present
lower
pneumonia
sever
index
psi
score
supplementari
tabl
patient
mild
symptom
stabl
initi
vital
sign
ed
physician
may
wait
laboratori
test
initi
iv
antibiot
patient
may
stratifi
lowrisk
group
bacteremia
could
chanc
avoid
unnecessari
blood
cultur
low
yield
therefor
time
decis
made
regard
initi
iv
antibiot
without
blood
cultur
min
alreadi
pass
timesav
effect
omit
blood
cultur
may
diminish
studi
sever
limit
first
studi
time
seri
studi
base
retrospect
review
registri
miss
random
mnar
occupi
small
fraction
includ
analysi
may
creat
bia
also
could
mani
confound
influenc
result
besid
intervent
second
baselin
characterist
two
group
intervent
significantli
differ
middl
east
respiratori
syndrom
coronaviru
merscov
outbreak
may
increas
sensit
ed
visit
popul
respiratori
symptom
may
one
reason
account
differ
third
adher
rate
bacteremia
score
may
low
expect
clinic
statist
signific
gener
evidencebas
chang
clinic
practic
physician
take
substanti
amount
time
effort
addit
period
adapt
time
need
calcul
score
make
decreas
adher
inevit
sever
patient
blood
cultur
iv
antibiot
urgent
addit
calcul
score
multipl
addit
difficult
use
excel
file
could
anoth
cumbersom
step
emerg
physician
crowd
ed
final
target
popul
includ
patient
cap
would
limit
broad
applic
tabl
blood
cultur
result
contamin
antibiot
regimen
chang
implement
bacteremia
predict
model
adjust
variabl
statist
signific
p
valu
b
age
sex
histori
diabet
mellitu
hypertens
heart
failur
cerebrovascular
diseas
renal
diseas
liver
diseas
known
neoplasm
systol
blood
pressur
respiratori
rate
puls
rate
bodi
temperatur
white
blood
cell
count
hematocrit
platelet
count
glucos
albumin
bun
psi
admiss
rate
number
patient
miss
variabl
use
analysi
patient
includ
analys
rule
clinic
field
despit
limit
could
observ
statist
signific
reduct
blood
cultur
intervent
without
affect
mortal
well
decreas
trend
initi
antibiot
administr
time
ed
length
stay
consid
low
adher
rate
score
system
thorough
educ
feedback
need
achiev
statist
signific
clinic
impact
time
initi
antibiot
administr
ed
length
stay
conclus
implement
bacteremia
predict
rule
cap
patient
reduc
blood
cultur
rate
without
affect
mortal
antibiot
regimen
bacteremia
predict
score
independ
associ
reduct
initi
antibiot
administr
time
ed
length
stay
prospect
multicent
studi
perform
evalu
impact
wide
implement
clinic
predict
rule
none
